actemra
Generic: tocilizumab
Labeler: genentech, inc.Drug Facts
Product Profile
Brand Name
actemra
Generic Name
tocilizumab
Labeler
genentech, inc.
Dosage Form
INJECTION, SOLUTION, CONCENTRATE
Routes
Active Ingredients
tocilizumab 200 mg/10mL
Manufacturer
Identifiers & Regulatory
Product NDC
50242-136
Product ID
50242-136_7f1b03d3-e0e1-4d90-b588-bb8d3ecb154a
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
BLA
Application Number
BLA125276
Listing Expiration
2026-12-31
Marketing Start
2010-01-08
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
50242136
Hyphenated Format
50242-136
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
actemra (source: ndc)
Generic Name
tocilizumab (source: ndc)
Application Number
BLA125276 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/10mL
Packaging
- 1 VIAL, SINGLE-USE in 1 BOX (50242-136-01) / 10 mL in 1 VIAL, SINGLE-USE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "7f1b03d3-e0e1-4d90-b588-bb8d3ecb154a", "openfda": {"nui": ["N0000190478", "N0000190480"], "unii": ["I031V2H011"], "rxcui": ["1441527", "1441530", "1657974", "1657976", "1657979", "1657980", "1657981", "1657982", "2106073", "2106075"], "spl_set_id": ["2e5365ff-cb2a-4b16-b2c7-e35c6bf2de13"], "pharm_class_epc": ["Interleukin-6 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Interleukin 6 Receptor Antagonists [MoA]"], "manufacturer_name": ["Genentech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 BOX (50242-136-01) / 10 mL in 1 VIAL, SINGLE-USE", "package_ndc": "50242-136-01", "marketing_start_date": "20100108"}], "brand_name": "ACTEMRA", "product_id": "50242-136_7f1b03d3-e0e1-4d90-b588-bb8d3ecb154a", "dosage_form": "INJECTION, SOLUTION, CONCENTRATE", "pharm_class": ["Interleukin 6 Receptor Antagonists [MoA]", "Interleukin-6 Receptor Antagonist [EPC]"], "product_ndc": "50242-136", "generic_name": "tocilizumab", "labeler_name": "Genentech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ACTEMRA", "active_ingredients": [{"name": "TOCILIZUMAB", "strength": "200 mg/10mL"}], "application_number": "BLA125276", "marketing_category": "BLA", "marketing_start_date": "20100108", "listing_expiration_date": "20261231"}